An Existing Oncology Platform.
A Defined Path to Institutional Scale.
An existing lyophilized intradermal immunobiology platform with indexed evidence and a structured path to institutional scale.
CONFIDENTIAL | INVESTIGATIONAL
The Mission
Transform published science and real-world evidence into a globally trusted oncology platform—UAE-incorporated, internationally developed, and built for global collaboration.
7
Indexed papers
3,572
Exposed patients
512
Structured core
154
PET-FDG subgroup
24,000+
Applications
One Product.
One Programme.
One Governance.
PLPC-DB™
PRODUCT PLATFORM
Lyophilized acellular processed secretome-derived formulation. Vial • Reconstitution • Intradermal.
ONCOVIX™
CLINICAL PROGRAMME
Supervised selection, timing, integration and follow-up. Built for safety, signals and outcomes.
STIP™
EVIDENCE GOVERNANCE
Identity, batch, biomarkers and audit trail. Human-reviewed. Transparent. Traceable.
Published Science.
Real-World Impact.
IDENTITY
Proteomic fingerprint
STABILITY
Processing + lyophilization
FUNCTION
Tumor-line ex vivo models
TRACEABILITY
STIP™ evidence methods
Human-Data Foundation
Now Being Qualified.
RWD SOURCES
Records • applications
labs • imaging
COHORT ACCOUNTING
Deduplication • inclusion
subset mapping
PRESPECIFIED ANALYSIS
Dictionary • endpoints
missingness
QUALIFIED RWE
Recalculation • limitations
human review
OBSERVATIONAL • NONRANDOMIZED • PENDING SOURCE RECONCILIATION
Why UAE?
REGULATORY READINESS
UAE regulatory pathway
INTERNATIONAL CLINICAL NETWORK
Cross-border development capability
Global Collaboration
PARTNER NETWORK
Global life sciences
TRANSLATIONAL EXECUTION
Science to market
CLINICAL DEVELOPMENT FOCUS
A broad platform — a disciplined start.
PROVISIONAL LEAD
Metastatic refractory melanoma
SECOND WORKSTREAM
Metastatic / refractory pancreatic cancer
FIRST EXPANSION
Refractory triple-negative breast cancer
TRANSLATIONAL EXECUTION
Cross-border capability. Roles disclosed.
🇦🇪 UAE SPONSOR
OGRD Alliance Biotech
IP • capital • governance
🇨🇱 CHILE CMC
Flowinmunocell
Natalia Muñoz-Godoy
🇪🇸 BARCELONA
BIOEXOCELL • BIOEXOLAB
Translation • feasibility
REGULATORY PATHWAY
Four gates to institutionalisation.
PRODUCT TRUTH
Signed definition • TPP • boundary
CMC LOCK
Process • CQA • potency • release
RWD QUALIFICATION
Cohorts • safety • SAP
BUSINESS MODEL
Partner-led. Evidence-generating.
🤝 CO-DEVELOPMENT
Partner-funded CMC and clinical work
💰 MILESTONES
Development, regulatory and sales
📄 LICENSING
Territory or indication-specific rights
Let’s Build the Next Generation Oncology Biotech Platform
We are seeking strategic partners, specialist investors and development collaborators aligned with evidence-driven oncology innovation and international scale-up.